[email protected]

老年医学与慢性病管理

Geriatric Medicine and Chronic Disease Management

您当前位置：首页 > 编委信息

杨军政

职称：

单位：广东省肾病药物工程技术研究中心

社会任职：美国Sigma Xi科学研究荣誉协会正式会员；中国中医药信息学会临床药学分会理事；深圳市科技库专家；广东保健协会中草药学会分会副主任委员；中国生物医学工程学会会员等。

个人简介

应邀入选美国Sigma Xi科学研究荣誉协会正式会员；Spring nature出版社reviewing editor；国际知名期刊Plos one 编委/学术编辑（中科院3区）；2022年、2023年、2024年泰晤士高等教育《 全球学术声誉调查》邀请专家；2022年和2024年泰晤士高等教育《中国学科评级调查》邀请专家；中国中医药信息学会临床药学分会理事；深圳市科技库专家；广东保健协会中草药学会分会副主任委员；中国生物医学工程学会会员；欧洲动脉粥样硬化学会（European Atherosclerosis Society）会员；曾先后就职或访学于韩国釜山国立大学、中科院深圳先进技术研究院、广州国家实验室（原生物岛实验室）以及慕尼黑工业大学；参与完成欧盟ERC项目、韩国科技部项目、德国DFG项目、国家自然基金项目等十余项；现任Journal of Translational Internal Medicine(IF=7.4，JCR Q1)、Interdisciplinary Sciences: Computational Life Sciences（IF=4.8，JCR Q1）、eye and vision （IF=4.0，JCR Q1）、Plos one（IF=2.6）等多家SCI期刊编委或青年编委；Burn&trauma、Phytotherapy Research等100多家国内外期刊审稿人；在Ageing research reviews（IF=12.1）、Phytomedicine（IF=8.3）、Journal of Ethnopharmacology（IF=5.4）等国内外期刊发表论文近80篇；申请专利30多项，授权发明专利7项，授权实用新型3项，获得新药证书1个，创新药临床批件2个，生产批件4个。

教育经历

学术贡献

  • 1、1. Gui-Xuan Lin, Min-Yi Li, Ting-Ting Duan, Tao Xia, Meng-Qiu Li, Lan-Qing Meng, Zi-Yang Lin, Min-Hua Li, Ying Lai, Bo-En Liang, Ying Du, Jun-Zheng Yang※. Schaftoside ameliorates MCD diet-induced nonalcoholic steatohepatitis via modulating immune microenvironment. Phytomedicine, 2025, IF=8.3 (中科院1区).
  • 2、2. Ziyang Lin, Zhaodi Wang, Van Pham Kim Thuong, Xianlong Zhang, Baien Liang, Minyi Li, Mengqiu Li, Tingting Duan, Zhenghai Li, Ping Li, Aihua Wu, Junzheng Yang※, Kun Bao, Bo Liu. Sanqi Qushi formula ameliorates renal injury in experimental membranous nephropathy rats by inhibiting the MEK/ERK signaling pathway. J Ethnopharmacol., 2025, 348:119813. 2025. IF=5.4 (中科院1区).
  • 3、3. Liu HJ, Miao H, Junzheng Yang, Liu F, Cao G, Zhao YY. Deciphering the role of lipoproteins and lipid metabolic alterations in ageing and ageing-associated renal fibrosis. Ageing Res Rev., 2023, 85:101861. IF=12.4 (中科院1区).
  • 4、4. Wang YN, Miao H, Hua MR, Junzheng Yang, Pei M, Yu HX, Wei LJ, Zou L, Zhang YM, Cao G, Zhao YY. Moshen granule ameliorates membranous nephropathy by blocking intrarenal renin-angiotensin system signaling via the Wnt1/β-catenin pathway. Phytomedicine, 2023, 114:154763. IF=8.3 (中科院1区).
  • 5、5. Ziyang Lin, Mingjie Liang, Xianlong Zhang, Zhuo Cen, Fengxin Kang, Baien Liang,
  • 6、Ying Lai, Minyi Li, Tingting Duan, Junzheng Yang※, Bo Liu. A Natural Compound Methylnissolin: Physicochemical Properties, Pharmacological Activities, Pharmacokinetics and Resource Development. A Natural Compound Methylnissolin: Physicochemical Properties, Pharmacological Activities, Pharmacokinetics and Resource Development. Drug Design, Development and Therapy. 2025, 19:3763-3777. IF=5.1(中科院2区).
  • 7、6. Xianlong Zhang, Mingjie Liang, Ziyang Lin, Minyi Li, Tingting Duan, Yun Han, Lanqing Meng, Mengqiu Li, Guixuan Lin,Tao Xia,Ying Lai,Boen Liang, Bingqiong Li, Minhua Li, Fengxin Kang, Quan Zhu, Zhenghai Li, Junzheng Yang※. Integrating network analysis and experimental validation to reveal the mechanism of Cuscuta chinensis lam. Extract in the treatment of IgA nephropathy. Journal of Functional Foods, 2025, 124(2):106658. IF=4.0 (中科院2区).
  • 8、7. Hua MR, Zhao YL, Junzheng Yang, Zou L, Zhao YY, Li X. Membranous nephropathy: Mechanistic insights and therapeutic perspectives. Int Immunopharmacol., 2023, 120:110317. IF=4.7 (中科院2区).
  • 9、8. Ren LL, Li XJ, Duan TT, Li ZH, Junzheng Yang, Zhang YM, Zou L, Miao H, Zhao YY. Transforming growth factor-β signaling: From tissue fibrosis to therapeutic opportunities.
  • 10、Chem Biol Interact., 2023, 369:110289. IF=5.4(中科院2区).
  • 11、9. Dan Li, Pei Feng, Yaru Wang, Junzheng Yang※. Exosomes applications in kidney diseases. Molecular Biology Reports, 2025, 52(1). IF=2.8.
  • 12、10. Ma S, Wang L, Zhang J, Geng L, Junzheng Yang※. The role of transcriptional and epigenetic modifications in astrogliogenesis. Peer J. 2024, IF=2.7.
  • 13、11. Duan T, Li M, Lin Z, Meng L, Li M, Xia T, Zhang X, Lin G, Yan L, Liang M, Zhu Q, Li Z, Junzheng Yang※. The Protective Effect of Vitexin on Hypertensive Nephropathy Rats. Kidney Blood Press Res., 2024, 49(1):753-762. IF=2.1.
  • 14、12. Duan T, Li M, Lie B, Lin Z, Li M, Xia T, Lin G, Meng L, Lu X, Li Z, Junzheng Yang※. The Protective Effect of the Asystasia chelonoides Extracts on Hypertensive Nephropathy Rats. Curr Pharm Biotechnol., 2023, 24(13):1708-1714. IF=2.6.
  • 15、13. Li M, Lie B, Duan T, Chen D, Xia T, Xie H, Lin G, Junzheng Yang※, Li Z. The Protective Effect of Bajijiasu on the Treatment of Hypertensive Nephropathy in Rats. Curr Mol Pharmacol., 2023;16(7):751-758. IF=2.9.
  • 16、14. Lin Z, Zhang J, Duan T, Junzheng Yang※, Yang Y. Trefoil factor 3 can stimulate Th17 cell response in the development of type 2 diabetes mellitus. Sci Rep., 2024, 14(1):10340. IF=3.9.
  • 17、15. Li Y, Junzheng Yang※, Li M, Zhang X, Du J, Zhao X, Xu Z, Lin J. The Extracts of Human Fetal Brain Induce the Differentiation of Human Umbilical Cord Mesenchymal Stem Cells into Dopaminergic Neuron Containing Cells. Cell Reprogram., 2020, 22(5):254-261. IF=1.7.

工作经历

  • ▪2021.08-至今 广东省肾病药物工程技术研究中心-药物评价室主任
  • ▪2019.11-2021.07 广州国家实验室（原生物岛实验室）-助理研究员
  • ▪2018.11 --2019.10 慕尼黑工业大学生物工程学院-research associate
  • ▪2017.10 --2018.11 公司名称 中科院深圳先进技术研究院-研究实习员
  • ▪2015.5-2017.11驼人医疗器械有限公司-研发部组长
  • ▪2014.07-2015.05 釜山国立大学医学院-研究实习员